BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Baron M, Grise P, Cornu JN. How botulinum toxin in neurogenic detrusor overactivity can reduce upper urinary tract damage? World J Nephrol 2016; 5(2): 195-203 [PMID: 26981445 DOI: 10.5527/wjn.v5.i2.195]
URL: https://www.wjgnet.com/2220-6124/full/v5/i2/195.htm
Number Citing Articles
1
Salvatore Cascio, Stuart O’Toole, Malcolm A. Lewis. Pediatric Surgery2022; : 1 doi: 10.1007/978-3-642-38482-0_204-1
2
Giulia I. Lane, Sean P. Elliott. Safely Avoiding Surgery in Adult Neurogenic BladderCurrent Bladder Dysfunction Reports 2018; 13(3): 169 doi: 10.1007/s11884-018-0479-y
3
Jacques Corcos, Mikolaj Przydacz. Consultation in Neurourology2018; : 213 doi: 10.1007/978-3-319-63910-9_12
4
Vasileios I. Sakalis, Rachel Oliver, Peter J. Guy, Melissa C. Davies. Macroplastique and Botox are superior to Macroplastique alone in the management of neurogenic vesicoureteric reflux in spinal cord injury population with presumed healthy bladdersThe Journal of Spinal Cord Medicine 2019; 42(4): 478 doi: 10.1080/10790268.2018.1433266
5
M. Baron, M.-A. Perrouin Verbe. Toxina botulínica en el tratamiento de la hiperactividad vesical neurógena y no neurológicaEMC - Urología 2024; 56(1): 1 doi: 10.1016/S1761-3310(23)48767-1
6
Salvatore Cascio, Stuart O’Toole, Malcolm A. Lewis. Pediatric Surgery2023; : 461 doi: 10.1007/978-3-662-43567-0_204